Clinical Trials Directory

Trials / Completed

CompletedNCT04228848

New Triple Hop Test Quality Assessment Tool

Examination of New Triple Hop Test Assessment Tool for Adults and Adolescents, Healthy and After Anterior Cruciate Ligament Injury

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
University of Haifa · Academic / Other
Sex
All
Age
12 Years – 45 Years
Healthy volunteers
Accepted

Summary

This study will develop a new jump assessment tool for the Triple Hop Test, and will test its reliability on adolescent and adult, healthy and post- anterior cruciate ligament (ACL) population. Creating a new assessment test for a jump test that incorporates the known movement components that are important after an ACL injury can improve patient evaluation, decision for return to sport activity and injury prevention.

Detailed description

Study population- Adults, women and men aged 20-45, boys and girls aged 12-15. uninjured population: non symptomatic subjects, without major injury in their history. Injured population: ACL injured subjects, 9-12 month after beginning of treatment/surgery. Stages of study: stage 1- The investigators will create a new high-quality literature-based assessment test for the triple hop test (NTHT). The test will have 10 sections, its score ranges from 0 to 14 points and a high score means poor performance. Stage 2- Performing reliability tests between and within the testers for NTHT. The tests will be done with the help of video photography of NTHT. Stage 3- Performing NTHT and THT tests on healthy adult and adolescent subjects and on ACL adult and adolescent subjects, assessing the NTHT by watching video performance.

Conditions

Interventions

TypeNameDescription
OTHERnew triple hop testNew jumping assessment will be performed in all included study groups. This new assessment includes quality evaluation.

Timeline

Start date
2020-07-26
Primary completion
2021-10-01
Completion
2021-10-01
First posted
2020-01-14
Last updated
2021-11-15

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT04228848. Inclusion in this directory is not an endorsement.